Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma

Published:2017-07-04 Issue:5 Volume:34 Page:308-319
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Berthold Frank¹,Hömberg Marc¹,Proleskovskaya Inna²,Mazanek Pavel³,Belogurova Margarita⁴,Ernst Angela⁵,Sterba Jaroslav³

Affiliation:

1. Department of Pediatric Oncology and Hematology, University of Cologne, Germany

2. Department of Pediatric Oncology and Hematology, University of Minsk, Belarus

3. Department of Pediatric Oncology and Hematology, University of Brno, Czech Republic

4. Department of Pediatric Oncology and Hematology, University of Cologne, St. Petersburg, Russia

5. Institute of Medical Statistics, Informatics, and Epidemiology, University of Cologne, Germany

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2017.1373314

Reference24 articles.

1. Annual Report 2013/14 German Childhood Cancer Registry. www.kinderkrebsregister.de p. 39. [Assessed 2016, August 9th]

2. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials

3. Advances in Risk Classification and Treatment Strategies for Neuroblastoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma;Cancer Letters;2024-04

2. Neuroblastoma Tumor Microenvironment: Non-Immune Cells and Exosomes;Pediatric Oncology;2024

3. Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach;Cancers;2022-10-19

4. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy;Scientific Reports;2022-09-08

5. Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies;Journal of Clinical Medicine;2022-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3